Epidermal growth factor signaling alterations in uterine papillary serous carcinoma (UPSC) associate with survival

被引:0
|
作者
Groeneweg, Jolijn W. [1 ,2 ]
Tambouret, Rosemary H. [1 ,2 ]
Borger, Darrell R. [1 ,2 ]
Foster, Rosemary [1 ,2 ]
Rueda, Bo R. [1 ,2 ]
Growdon, Whitfield B. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
D O I
10.1158/1538-7445.AM2012-4556
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4556
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma
    Bancher-Todesca, D
    Neunteufel, W
    Williams, KE
    Prainsack, D
    Breitenecker, G
    Friedlander, ML
    Hacker, NF
    GYNECOLOGIC ONCOLOGY, 1998, 71 (03) : 344 - 347
  • [32] Uterine papillary serous carcinoma: a review
    Gehrig, Paola A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (06) : 809 - 816
  • [33] UTERINE PAPILLARY SEROUS CARCINOMA REVISITED
    HENDRICKSON, MR
    LONGACRE, TA
    KEMPSON, RL
    GYNECOLOGIC ONCOLOGY, 1994, 54 (03) : 261 - 263
  • [34] Treatment of uterine papillary serous carcinoma
    Ricci, Stephanie
    Fader, Amanda Nickles
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (10): : 819 - 827
  • [35] Can primary recurrences in surgical stage I-II uterine papillary serous carcinoma (UPSC) patients be salvaged?
    Fader, A. Nickles
    Rose, P. G.
    Frasure, H.
    Gehrig, P. A.
    Moore, K. N.
    Havrilesky, L. J.
    Huh, W. K.
    Axtell, A. E.
    O'Malley, D. M.
    Zanotti, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] Improved Outcomes in Uterine Papillary Serous Carcinoma (UPSC) With Concomitant Versus Sequential Chemotherapy (CT) and Radiation Therapy (RT)
    Stewart, R.
    Griffith, M.
    Kolev, V.
    Koulos, J.
    Anderson, L.
    Naam, S.
    Chadha, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E270 - E271
  • [37] Molecular alterations in uterine serous carcinoma
    Hayes, Monica Prasad
    Ellenson, Lora Hedrick
    GYNECOLOGIC ONCOLOGY, 2010, 116 (02) : 286 - 289
  • [38] The Percentage of Positive Lymph Nodes is a Predictor of Survival in Uterine Papillary Serous Carcinoma
    Lee, L. J.
    Schultz, D.
    Tanaka, C.
    Viswanathan, A. N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S372 - S372
  • [39] Family History of Cancer Shows Improved Survival in Uterine Papillary Serous Carcinoma
    Parsons, L. H. Palavalli
    Lin, K. Y.
    Miller, D. S.
    Richardson, D.
    Carlson, M.
    Kehoe, S.
    Lea, J. S.
    GYNECOLOGIC ONCOLOGY, 2017, 147 (01) : 225 - 226
  • [40] Rapamycin potentiates the effects of paclitaxel in uterine papillary serous carcinoma (UPSC) cells through inhibition of cell proliferation and induction of apoptosis
    Mendivil, Albert
    Zhou, Chunxiao
    Cantrell, Leigh
    Gehrig, Paola
    Malloy, Kim
    Bae-Jump, Victoria L.
    CANCER RESEARCH, 2010, 70